Drug Trial Radar · NCT00675714
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Last checked: Nov 19, 2026Latest source record: Nov 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,126
Actual
Start
Jan 2004
Primary completion
Sep 2018
Study completion Jul 15, 2019
Sponsor
- Lead sponsor
- The University of Texas Medical Branch, GalvestonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- U.S. Department of Education; National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)
- First posted
- May 12, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolol,ketoconazole, inhospital exercise and home exercise.
Conditions
- Burns
Interventions
Stable Isotope Infusion StudyProcedure
1-8 hour stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues.
Collection of blood and tissuesProcedure
Blood draw with each stable isotope infusion study and weekly Tissue biopsy: skin, fat, muscle at stable isotope infusion study
Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRIProcedure
Testing to be done following every stable isotope infusion study to measure muscle, fat and bone tissues.
HumatropeDrug
Humatrope (Growth Hormone) dose:0.05mg - 0.2mg/kg/day SQ daily for up to 2 years post burn injury.
KetoconazoleDrug
Ketoconazole administration (or other glucocorticoid blocker--itraconazole or fluconazole) PO daily for up to 2 years post burn injury
OxandroloneDrug
oxandrolone (or other anabolic steroid-testosterone or nandrolone) daily for up to 2 years post burn injury
PropranololDrug
Propranolol (or other beta adrenergic blocker--metoprolol, inderol), PO administration daily for up to 2 years post burn injury.
Oxandrolone and propranolol combinedDrug
Daily administration of oxandrolone and propranolol to be given for up to 2 years post burn injury.
Humatrope and propranolol combinedDrug
Humatrope (growth hormone) and propranolol administration daily for up to 2 years post burn injury.
PlaceboDrug
placebo to be given once a day for up to two years post burn injury.
Exercise--Hospital supervised intensive exercise programBehavioral
intensive exercise program supervised by trained personnel in the hospital environment for six up to twelve week program.
Home exercise programBehavioral
Home intensive exercise program: training occurs in hospital then patient sent home to continue exercise program for six weeks and up to 12 weeks at home.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measures of muscle wasting, weakness, immunosuppression chronic bone loss and decreased growth with increases in metabolic, hemodynamic, inflammatory and scarring responses.Time frame: Admission to burn unit and up to 2 years post burn and yearly after that
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Texas Medical Branch
Galveston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.